HomeCompareEADSY vs MRK

EADSY vs MRK: Dividend Comparison 2026

EADSY yields 1.21% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 EADSY wins by $8.67M in total portfolio value· pulled ahead in Year 4
10 years
EADSY
EADSY
● Live price
1.21%
Share price
$47.25
Annual div
$0.57
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$8.73M
Annual income
$7,527,263.49
Full EADSY calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — EADSY vs MRK

📍 EADSY pulled ahead of the other in Year 4

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodEADSYMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, EADSY + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
EADSY pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

EADSY
Annual income on $10K today (after 15% tax)
$102.54/yr
After 10yr DRIP, annual income (after tax)
$6,398,173.97/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, EADSY beats the other by $6,389,845.56/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of EADSY + MRK for your $10,000?

EADSY: 50%MRK: 50%
100% MRK50/50100% EADSY
Portfolio after 10yr
$4.39M
Annual income
$3,768,530.82/yr
Blended yield
85.82%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

EADSY
Analyst Ratings
4
Buy
2
Hold
Consensus: Buy
Price Target
$51.00
+7.9% upside vs current
Range: $51.00 — $51.00
Altman Z
1.7
Piotroski
7/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

EADSY buys
0
MRK buys
0
No recent congressional trades found for EADSY or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricEADSYMRK
Forward yield1.21%2.76%
Annual dividend / share$0.57$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%32.7%
Portfolio after 10y$8.73M$56.8K
Annual income after 10y$7,527,263.49$9,798.13
Total dividends collected$8.61M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusBuyBuy
Analyst price target$51.00$128.54

Year-by-year: EADSY vs MRK ($10,000, DRIP)

YearEADSY PortfolioEADSY Income/yrMRK PortfolioMRK Income/yrGap
1$10,941$241.27$11,206$366.19$265.00MRK
2$12,201$493.42$12,650$502.35$449.00MRK
3$14,083$1,028.43$14,407$694.19$324.00MRK
4← crossover$17,288$2,218.90$16,585$967.82+$703.00EADSY
5$23,589$5,091.28$19,342$1,363.89+$4.2KEADSY
6$38,226$12,985.16$22,913$1,947.19+$15.3KEADSY
7$80,232$39,330.96$27,662$2,823.89+$52.6KEADSY
8$240,152$154,303.60$34,159$4,173.35+$206.0KEADSY
9$1,120,258$863,295.30$43,337$6,308.80+$1.08MEADSY
10$8,725,940$7,527,263.49$56,776$9,798.13+$8.67MEADSY

EADSY vs MRK: Complete Analysis 2026

EADSYStock

Airbus SE engages in the designing, manufacturing, and delivering aerospace products, services, and solutions worldwide. It operates through three segments: Airbus, Airbus Helicopters, and Airbus Defence and Space. The Airbus segment develops, manufactures, markets, and sells commercial jet aircraft of approximately 100 seats; and regional turboprop aircraft and aircraft components, as well as provides aircraft conversion and related services. The Airbus Helicopters segment engages in the development, manufacturing, marketing, and sale of civil and military helicopters; and provision of helicopter related services. The Airbus Defence and Space segment designs, develops, delivers, and supports military aircraft, such as combat, mission, transport, tanker aircraft, and their associated services; and offers unmanned aerial systems. This segment also offers civil and defense space systems for telecommunications, earth observations, navigation, science, and orbital systems; missile systems; and space launcher systems, as well as services around data processing from platforms, secure communication, and cyber security. The company was formerly known as Airbus Group SE and changed its name to Airbus SE in April 2017. Airbus SE was incorporated in 1998 and is based in Leiden, the Netherlands.

Full EADSY Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this EADSY vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

EADSY vs SCHDEADSY vs JEPIEADSY vs OEADSY vs KOEADSY vs MAINEADSY vs JNJEADSY vs ABBVEADSY vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.